Cancer News and Research

Latest Cancer News and Research

Professor receives $1.3M EUREKA grant to explore communication between cytoplasm and nucleus

Professor receives $1.3M EUREKA grant to explore communication between cytoplasm and nucleus

Researchers use ARRAYit Microarray Platform to discover important biomarkers

Researchers use ARRAYit Microarray Platform to discover important biomarkers

PET scan shows promise in predicting patients with inoperable lung cancer

PET scan shows promise in predicting patients with inoperable lung cancer

New research identifies protein that controls formation of different types of mature blood cells

New research identifies protein that controls formation of different types of mature blood cells

Study discovers biomarker that helps doctors to accurately diagnose Parkinson's at earlier stage

Study discovers biomarker that helps doctors to accurately diagnose Parkinson's at earlier stage

LSUHSC receives $2.76M grant to study how HIV affect oral bacterial communities

LSUHSC receives $2.76M grant to study how HIV affect oral bacterial communities

Scientists devised technique to make antibody-drug conjugates, basis of new therapies

Scientists devised technique to make antibody-drug conjugates, basis of new therapies

Eddingpharm Secures Immutep’s Immufact IMP321 For Growing Stable

Eddingpharm Secures Immutep’s Immufact IMP321 For Growing Stable

Immutep, Eddingpharm partner to develop and commercialize ImmuFact IMP321

Immutep, Eddingpharm partner to develop and commercialize ImmuFact IMP321

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

Experimental Therapeutics, Debiopharm join to develop oral small molecules targeting new class of epigenetic modulators

Kiadis Pharma signs Services Agreement with GRCBDS for Phase II clinical study with ATIR

Kiadis Pharma signs Services Agreement with GRCBDS for Phase II clinical study with ATIR

Six prominent surgeons awarded Honorary Fellowship at Clinical Congress of ACS

Six prominent surgeons awarded Honorary Fellowship at Clinical Congress of ACS

Researchers discover how cancer development molecule maintains its genome integrity

Researchers discover how cancer development molecule maintains its genome integrity

Renowned leaders in diabetes prevention, treatment, research to descend at Jefferson Symposium

Renowned leaders in diabetes prevention, treatment, research to descend at Jefferson Symposium

Newly discovered compound could be developed as antifungal drug to treat fungal infections

Newly discovered compound could be developed as antifungal drug to treat fungal infections

State highlights: Wendy Davis announces Texas gubernatorial run; Calif. gov. signs pharmacist scope-of-practice bill

State highlights: Wendy Davis announces Texas gubernatorial run; Calif. gov. signs pharmacist scope-of-practice bill

Scientists at Oklahoma Medical Research Foundation identify six new Sj-gren-related genes

Scientists at Oklahoma Medical Research Foundation identify six new Sj-gren-related genes

Winners of VCCircle Healthcare Awards announced

Winners of VCCircle Healthcare Awards announced

AbbVie announces HUMIRA phase II study results for treating hidradenitis suppurativa

AbbVie announces HUMIRA phase II study results for treating hidradenitis suppurativa

Research: VIP interneurons inhibit activation of other inhibitory neurons in cerebral cortex

Research: VIP interneurons inhibit activation of other inhibitory neurons in cerebral cortex

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.